Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Acute Kidney Injury D058186 34 associated lipids
Airway Remodeling D056151 3 associated lipids
Acute Coronary Syndrome D054058 11 associated lipids
Hypoalphalipoproteinemias D052456 5 associated lipids
Atherosclerosis D050197 85 associated lipids
Dyslipidemias D050171 7 associated lipids
Cholecystitis, Acute D041881 1 associated lipids
Pulmonary Disease, Chronic Obstructive D029424 16 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Coronary Stenosis D023921 6 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Stroke D020521 32 associated lipids
Latex Hypersensitivity D020315 1 associated lipids
Intracranial Hemorrhage, Hypertensive D020299 1 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Venous Thrombosis D020246 11 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Carotid Artery Injuries D020212 8 associated lipids
Sleep Apnea, Obstructive D020181 9 associated lipids
Basal Ganglia Hemorrhage D020145 1 associated lipids
Thrombophilia D019851 6 associated lipids
Endotoxemia D019446 27 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Atrial Premature Complexes D018880 1 associated lipids
Sepsis D018805 11 associated lipids
Systemic Inflammatory Response Syndrome D018746 4 associated lipids
Ventricular Dysfunction, Left D018487 33 associated lipids
Osteoblastoma D018215 1 associated lipids
Aortic Aneurysm, Abdominal D017544 5 associated lipids
Hypertrophy, Left Ventricular D017379 12 associated lipids
beta-Thalassemia D017086 5 associated lipids
Carotid Stenosis D016893 15 associated lipids
Death, Sudden, Cardiac D016757 12 associated lipids
Yang Deficiency D016711 3 associated lipids
Diabetes, Gestational D016640 8 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Peripheral Vascular Diseases D016491 8 associated lipids
Helicobacter Infections D016481 21 associated lipids
Bacteremia D016470 9 associated lipids
Leukemia, Myeloid, Acute D015470 19 associated lipids
Glomerulonephritis, Membranous D015433 6 associated lipids
Weight Loss D015431 56 associated lipids
Weight Gain D015430 101 associated lipids
Myocardial Reperfusion Injury D015428 20 associated lipids
Reperfusion Injury D015427 65 associated lipids
Zellweger Syndrome D015211 39 associated lipids
Wounds and Injuries D014947 20 associated lipids
Weil Disease D014895 2 associated lipids
Granulomatosis with Polyangiitis D014890 5 associated lipids
Vitamin E Deficiency D014811 29 associated lipids
Ventricular Fibrillation D014693 16 associated lipids
Vascular Diseases D014652 16 associated lipids
Varicose Veins D014648 7 associated lipids
Uveitis D014605 14 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Uremia D014511 33 associated lipids
Ulcer D014456 16 associated lipids
Tooth, Impacted D014095 9 associated lipids
Thrombosis D013927 49 associated lipids
Thromboembolism D013923 6 associated lipids
Thrombocytopenia D013921 15 associated lipids
Thrombocythemia, Essential D013920 9 associated lipids
Thromboangiitis Obliterans D013919 4 associated lipids
Thrombasthenia D013915 4 associated lipids
Takayasu Arteritis D013625 3 associated lipids
Tachycardia, Supraventricular D013617 3 associated lipids
Tachycardia, Paroxysmal D013614 2 associated lipids
Tachycardia D013610 7 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Strongyle Infections, Equine D013319 1 associated lipids
Streptococcal Infections D013290 4 associated lipids
Stomach Volvulus D013277 1 associated lipids
Stomach Ulcer D013276 75 associated lipids
Gastric Dilatation D013271 1 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Sneezing D012912 6 associated lipids
Shock, Septic D012772 11 associated lipids
Shock D012769 11 associated lipids
Seizures D012640 87 associated lipids
Sclerosis D012598 5 associated lipids
Scleroderma, Systemic D012595 16 associated lipids
Salmonella Infections, Animal D012481 9 associated lipids
Rhinitis D012220 10 associated lipids
Retinal Vein Occlusion D012170 2 associated lipids
Retinal Diseases D012164 4 associated lipids
Retinal Detachment D012163 10 associated lipids
Respiratory Insufficiency D012131 10 associated lipids
Respiratory Hypersensitivity D012130 18 associated lipids
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Respiration Disorders D012120 5 associated lipids
Renal Artery Obstruction D012078 8 associated lipids
Raynaud Disease D011928 7 associated lipids
Radiculopathy D011843 1 associated lipids
Radiation Injuries, Experimental D011833 11 associated lipids
Purpura, Thrombotic Thrombocytopenic D011697 6 associated lipids
Purpura, Schoenlein-Henoch D011695 5 associated lipids
Pulmonary Heart Disease D011660 2 associated lipids
Pulmonary Embolism D011655 5 associated lipids
Pulmonary Edema D011654 23 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Yu W and Xu L [Effects of acetylsalvianolic acid A on arachidonic acid metabolism in platelets]. 1998 Yao Xue Xue Bao pmid:11938938
Eikelboom JW et al. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. 2002 Circulation pmid:11940542
Huang K et al. Role of selenium in cytoprotection against cholesterol oxide-induced vascular damage in rats. 2002 Atherosclerosis pmid:11947907
Signorello MG et al. Effect of homocysteine on arachidonic acid release in human platelets. 2002 Eur. J. Clin. Invest. pmid:11952814
Hu X et al. [The influence of nasal continual positive airway pressure on some vasoactive substances in patients with obstructive sleep apnea syndrome]. 2002 Zhonghua Jie He He Hu Xi Za Zhi pmid:11953098
Burleigh ME et al. Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice. 2002 Circulation pmid:11956125
Wainwright CL et al. NCX4016 (NO-aspirin) reduces infarct size and suppresses arrhythmias following myocardial ischaemia/reperfusion in pigs. 2002 Br. J. Pharmacol. pmid:11959790
Knijff-Dutmer EA et al. Platelet function is inhibited by non-selective non-steroidal anti-inflammatory drugs but not by cyclo-oxygenase-2-selective inhibitors in patients with rheumatoid arthritis. 2002 Rheumatology (Oxford) pmid:11961179
Hayashi M et al. The levels of five markers of hemostasis and endothelial status at different stages of normotensive pregnancy. 2002 Acta Obstet Gynecol Scand pmid:11966476
Jeng JH et al. Modulation of platelet aggregation by areca nut and betel leaf ingredients: roles of reactive oxygen species and cyclooxygenase. 2002 Free Radic. Biol. Med. pmid:11978487
Nakamura H et al. Difference in urinary 11-dehydro TXB2 and LTE4 excretion in patients with rheumatoid arthritis. 2001 Nov-Dec Prostaglandins Leukot. Essent. Fatty Acids pmid:11993724
Yan C and Feng Y [Effects of butylphthalide on extracellular 6-keto-PGF1 alpha, TXB2 and 6-keto-PGF1 alpha/TXB2 ratio in cultured rat cortical neurons]. 1998 Yao Xue Xue Bao pmid:12016850
Sakai H et al. E3040 sulphate, a novel thromboxane synthase inhibitor, blocks the Cl- secretion induced by platelet-activating factor in isolated rat colon. 2002 Br. J. Pharmacol. pmid:12023941
van Kraaij DJ et al. A comparison of the effects of nabumetone vs meloxicam on serum thromboxane B2 and platelet function in healthy volunteers. 2002 Br J Clin Pharmacol pmid:12047490
Jung YS et al. Antithrombotic effect of onion in streptozotocin-induced diabetic rat. 2002 Prostaglandins Leukot. Essent. Fatty Acids pmid:12054917
Jung K et al. The effect of dietary intervention through the modification of fatty acids composition and antioxidant vitamin intake on plasma TXB(2) level in Korean postmenopausal women with hypercholesterolemia. 2002 J. Korean Med. Sci. pmid:12068132
Tsukamoto H et al. Simultaneous quantification of prostaglandins, isoprostane and thromboxane in cell-cultured medium using gas chromatography-mass spectrometry. 2002 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:12076690
Robak J and Kasperczyk H [Prostaglandin synthetase components (author's transl)]. 1979 Postepy Biochem. pmid:120943
Leese PT et al. Valdecoxib does not impair platelet function. 2002 Am J Emerg Med pmid:12098171
Jankov RP et al. Thromboxane A(2) receptors mediate pulmonary hypertension in 60% oxygen-exposed newborn rats by a cyclooxygenase-independent mechanism. 2002 Am. J. Respir. Crit. Care Med. pmid:12119234
Cipollone F et al. Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. 2002 Circulation pmid:12135935
Association between ibuprofen, aspirin therapy found. 2002 J Am Dent Assoc pmid:12136787
Wolfram RM et al. Effect of black tea on (iso-)prostaglandins and platelet aggregation in healthy volunteers. 2002 May-Jun Prostaglandins Leukot. Essent. Fatty Acids pmid:12144875
Gómez-Gaviro MV et al. Structure-function relationship and role of tumor necrosis factor-alpha-converting enzyme in the down-regulation of L-selectin by non-steroidal anti-inflammatory drugs. 2002 J. Biol. Chem. pmid:12147693
Khan AA et al. In vivo selectivity of a selective cyclooxygenase 2 inhibitor in the oral surgery model. 2002 Clin. Pharmacol. Ther. pmid:12152003
Kirchheiner J et al. Enantiospecific effects of cytochrome P450 2C9 amino acid variants on ibuprofen pharmacokinetics and on the inhibition of cyclooxygenases 1 and 2. 2002 Clin. Pharmacol. Ther. pmid:12152005
Rinder HM et al. Effects of meloxicam on platelet function in healthy adults: a randomized, double-blind, placebo-controlled trial. 2002 J Clin Pharmacol pmid:12162470
Wong DA et al. Discrete role for cytosolic phospholipase A(2)alpha in platelets: studies using single and double mutant mice of cytosolic and group IIA secretory phospholipase A(2). 2002 J. Exp. Med. pmid:12163563
Alarayyed NA et al. Differential actions of naftopidil, doxazosin and nifedipine on platelet thromboxane generation and platelet-derived growth factor efflux in vitro. 2002 Aug-Sep Platelets pmid:12189011
Gordon SM et al. Peripheral prostanoid levels and nonsteroidal anti-inflammatory drug analgesia: replicate clinical trials in a tissue injury model. 2002 Clin. Pharmacol. Ther. pmid:12189364
Van Hecken A et al. Effects of enteric-coated, low-dose aspirin on parameters of platelet function. 2002 Aliment. Pharmacol. Ther. pmid:12197849
Wang L et al. Enhancement of human platelet activation by the combination of low concentrations of collagen and rabbit anticardiolipin antibodies. 2002 Br. J. Haematol. pmid:12199800
Park CH et al. Investigations of new lead structures for the design of novel cyclooxygenase-2 inhibitors. 2002 Eur J Med Chem pmid:12204472
Li JB et al. [A further research on physiopathological basis of "Liver Yang Forming Wind Syndrome"]. 2000 Hunan Yi Ke Da Xue Xue Bao pmid:12205996
Wilner KD et al. Celecoxib does not affect the antiplatelet activity of aspirin in healthy volunteers. 2002 J Clin Pharmacol pmid:12211219
Molina V et al. D-003, a potential antithrombotic compound isolated from sugar cane wax with effects on arachidonic acid metabolites. 2002 Prostaglandins Leukot. Essent. Fatty Acids pmid:12213431
Koizumi T et al. Inhibition of endogenous nitric oxide during endotoxemia in awake sheep - effects of Nomega-nitro-l-arginine on the distribution of pulmonary vascular resistance and prostanoid products. 2002 Exp. Lung Res. pmid:12217213
Khan I et al. Altered expression of Na(+)/H(+) exchanger isoforms 1 and 3 in clipped and unclipped kidneys of a 2-kidney-1-clip Goldblatt model of hypertension. 2002 Nephron pmid:12218313
Chen TL et al. [Effects of fast decompression on prostaglandins content in cerebral tissue of guinea pigs]. 2002 Space Med Med Eng (Beijing) pmid:12222577
Schelzig H et al. Role of recombinant hirudin in a pig-to-human lung transplantation model. 2002 Transplant. Proc. pmid:12270449
Huang CG et al. Effect of berberine on arachidonic acid metabolism in rabbit platelets and endothelial cells. 2002 Thromb. Res. pmid:12297129
Appleyard CB et al. Temporal changes in colonic vascular architecture and inflammatory mediator levels in animal models of colitis. 2002 Dig. Dis. Sci. pmid:12353846
Saldeen P et al. Structural, functional and circulatory placental changes associated with impaired glucose metabolism. 2002 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:12381475
Davì G et al. Platelet activation in obese women: role of inflammation and oxidant stress. 2002 Oct 23-30 JAMA pmid:12387653
Fike CD et al. Arachidonic acid metabolites and an early stage of pulmonary hypertension in chronically hypoxic newborn pigs. 2003 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:12388340
Kim H et al. Effect of mannitol on Helicobacter pylori-induced cyclooxygenase-2 expression in gastric epithelial AGS cells. 2002 Pharmacology pmid:12393940
Shashikant MP et al. Physicochemical properties of perfluorochemical liquids influence ventilatory requirements, pulmonary mechanics, and microvascular permeability during partial liquid ventilation following intestinal ischemia/reperfusion injury. 2002 Crit. Care Med. pmid:12394959
Saareks V et al. Opposite effects of nicotinic acid and pyridoxine on systemic prostacyclin, thromboxane and leukotriene production in man. 2002 Pharmacol. Toxicol. pmid:12403056
Yokoyama C et al. Prostacyclin-deficient mice develop ischemic renal disorders, including nephrosclerosis and renal infarction. 2002 Circulation pmid:12403673
Evgenov OV et al. Methylene blue reduces pulmonary oedema and cyclo-oxygenase products in endotoxaemic sheep. 2002 Eur. Respir. J. pmid:12412689